Elizabeth H.Z. Thompson - Aug 12, 2024 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
Stock symbol
ACAD
Transactions as of
Aug 12, 2024
Transactions value $
$0
Form type
4
Date filed
8/13/2024, 06:05 PM
Previous filing
Jul 2, 2024
Next filing
Oct 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the Stock Option will vest and become exercisable on July 29, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F3 50% of the restricted stock units vest on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028.